The Society for Leukocyte Biology will hold a session at its annual meeting September 27-29 in Raleigh, North Carolina that features Ian Crozier, M.D., the famed Ebola doctor and patient, who is believed to be the sickest Ebola survivor ever. During his talk, he will relate his experience as WHO-deployed clinician (Kenema ETU, Sierra Leone), then as Ebola patient (Emory University Hospital) and finally as an Ebola survivor. As he presents his own case, he will highlight key perspectives about the care provided at an African bedside, the care received at an Emory bedside, and the emerging sequelae of Ebola Virus Disease. This specific talk will focus on Ebola-related eye disease, the potential questions to be asked of finding persistent Ebola virus in an immune-privileged sanctuary site, and the implications for West African survivors.
"We are excited to have Dr. Crozier speak at our meeting," said Ann Richmond, President of the Society for Leukocyte Biology. "His perspectives both as a treating physician and as a patient will really help our members see that their work extends well beyond the laboratories and to bedsides both at home and abroad."
Ian Crozier is a Vanderbilt-trained infectious diseases specialist originally from Bulawayo, Zimbabwe. Over the past six years, primarily at the Infectious Diseases Institute (Kampala, Uganda), his work has focused on developing clinical reasoning skills in African doctors providing complex HIV/AIDS care. In August 2014, he was deployed by the World Health Organization to the Ebola Treatment Unit in Kenema, Sierra Leone. After becoming infected, he was evacuated to Emory University Hospital, becoming critically ill, but emerging after a 6 week hospitalization. Two months after clearing the virus from his blood, he developed sight-threatening ocular inflammation with high amounts of viable Ebola virus detected in the eye. He has been called potentially the sickest Ebola survivor ever, and provides a unique, bilingual and dual perspective as an Ebola doctor and Ebola survivor.
The Society for Leukocyte Biology was established in 1971. With more than 700 members located around the world, the Society works to promote research and scientific endeavors in the field of leukocyte biology and immunology; to make the field known to a wide audience that includes the scientific community as well as those outside of that community; to extend current understanding of the importance of leukocyte biology, particularly in regard to the physiology of these cells and their relationship to the immune system; and to foster education and understanding of leukocytes' importance in disease and their application to biotechnology. The Society holds a meeting each year of researchers and scientists working in a broad range of fields, but mostly concentrating on immunology. For more information about this year's annual meeting, held in Raleigh, NC, visit http://leukocytebiology.